Articles

Search all Infectious Diseases and Therapy articles

Filter by

Volume:

Sort by

Date published:

New to old Old to new

Showing 1-50 of 984 articles

Opportunities to Enhance Diagnostic Testing and Antimicrobial Stewardship: A Qualitative Multinational Survey of Healthcare Professionals
Timothy Jinks
Sumithra Subramaniam
Clare Willis
Original Research Open access 03 June 2024
Clinical Outcome and 7-Day Virological Clearance in High-Risk Patients with Mild–Moderate COVID-19 Treated with Molnupiravir, Nirmatrelvir/Ritonavir, or Remdesivir
Francesca Bai
Tomaso Beringheli
Giulia Marchetti
Original Research Open access 03 June 2024
Ceftazidime-Avibactam in the Treatment of Patients with Bacteremia or Nosocomial Pneumonia: A Systematic Review and Meta-analysis
Ryan K. Shields
Juan P. Horcajada
Tobias Welte
Original Research Open access 31 May 2024
Implementation of Guideline-Based HBV Reactivation Management in Patients with Chronic HBV Infections of HBsAg or Resolved HBV Infection Undergoing Immunosuppressive Therapy
Yasuhito Tanaka
Daisuke Nakamoto
Harriet Dickinson
Original Research Open access 29 May 2024
Immunogenicity of mRNA-1273 and BNT162b2 in Immunocompromised Patients: Systematic Review and Meta-analysis Using GRADE
Sushma Kavikondala
Katrin Haeussler
Nicolas Van de Velde
Review Open access 27 May 2024
Lifetime Health and Economic Burden of Invasive Pneumococcal Diseases Attributable to V116 Serotypes Among Adults in the United States
Zinan Yi
Kelly D. Johnson
Kwame Owusu-Edusei
Original Research Open access 25 May 2024
Population Pharmacokinetics of Bepirovirsen in Healthy Participants and Participants with Chronic Hepatitis B Virus Infection: Results from Phase 1, 2a, and 2b Studies
Amir S. Youssef
Mohamed Ismail
Ahmed Nader
Original Research Open access 25 May 2024
Utility of SARS-CoV-2 Subgenomic RNA in Kidney Transplant Recipients Receiving Remdesivir
Genoveva Cuesta
Judit Cacho
Marta Bodro
Brief Report Open access 24 May 2024
Responding to the Call to Action: Framework to Accelerate Clinical Data Generation for Antiretroviral Use in Pregnant Individuals with HIV
Vani Vannappagari
Scott McCallister
Annemiek de Ruiter
Commentary Open access 22 May 2024
A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19
Wang-Da Liu
Po-Hao Feng
Wang-Huei Sheng
Original Research Open access 21 May 2024
The Multifaceted Burden of Respiratory Syncytial Virus (RSV) Infections in Young Children on the Family: A European Study
Ilona Trautmannsberger
Barbara Plagg
the ResQ Family study group
Original Research Open access 20 May 2024
Molnupiravir Use Among Patients with COVID-19 in Real-World Settings: A Systematic Literature Review
Julia Richmond DiBello
Valerie T. Raziano
Deanna D. Hill
Review Open access 14 May 2024 Pages: 1177 - 1198
Clinical Characteristics and Fatality Risk Factors for Patients with Listeria monocytogenes Infection: A 12-Year Hospital-Based Study in Xi’an, China
Wen Xu
Mei-Juan Peng
Ye Zhang
Original Research Open access 11 May 2024 Pages: 1359 - 1378
Cost-effectiveness of PCV20 to Prevent Pneumococcal Disease in the Pediatric Population: A German Societal Perspective Analysis
An Ta
Felicitas Kühne
Johnna Perdrizet
Original Research Open access 11 May 2024 Pages: 1333 - 1358
Cost-effectiveness Analysis of Maternal Immunization with RSVpreF Vaccine for the Prevention of Respiratory Syncytial Virus Among Infants in Spain
Javier Álvarez Aldean
Irene Rivero Calle
Virginia Lozano
Original Research Open access 11 May 2024 Pages: 1315 - 1331
Implementation of AZD7442 (Tixagevimab/Cilgavimab) COVID-19 Pre-exposure Prophylaxis (PrEP) in the Largest Health Maintenance Organization in Israel: Real-world Uptake and Sociodemographic and Clinical Characteristics Across Immunocompromised Patient Groups
Samah Hayek
Joseph Levy
Alon Peretz
Brief Report Open access 10 May 2024 Pages: 1379 - 1389
Distribution of Nosocomial Pathogens and Antimicrobial Resistance among Patients with Burn Injuries in China: A Comprehensive Research Synopsis and Meta-Analysis
Yuhui Yang
Qingling Zeng
Gaoming Li
Original Research Open access 09 May 2024 Pages: 1291 - 1313
Clinical Outcomes of Integrase Strand Transfer Inhibitors Containing Antiretroviral Therapy in HIV-2: A Narrative Review
Wendy J. Boschloo
Berend J. van Welzen
Review Open access 09 May 2024 Pages: 1161 - 1175
Penetration Profile of Terbinafine Compared to Amorolfine in Mycotic Human Toenails Quantified by Matrix-Assisted Laser Desorption Ionization–Fourier Transform Ion Cyclotron Resonance Imaging
Nicolas Joly-Tonetti
Raphael Legouffe
Martin Schaller
Original Research Open access 07 May 2024 Pages: 1281 - 1290
Respiratory Syncytial Virus Sequelae Among Adults in High-Income Countries: A Systematic Literature Review and Meta-analysis
Egbe Ubamadu
Estefania Betancur
Elizabeth Begier
Review Open access 06 May 2024
Penetration Profiles of Four Topical Antifungals in Mycotic Human Toenails Quantified by Matrix-Assisted Laser Desorption Ionization–Fourier Transform Ion Cyclotron Resonance Imaging
Nicolas Joly-Tonetti
Raphael Legouffe
Martin Schaller
Original Research Open access 04 May 2024 Pages: 1269 - 1279
Efficacy, Safety, and Pharmacokinetics of AZD7442 (Tixagevimab/Cilgavimab) for Prevention of Symptomatic COVID-19: 15-Month Final Analysis of the PROVENT and STORM CHASER Trials
Myron J. Levin
Andrew Ustianowski
Mark T. Esser
Original Research Open access 04 May 2024 Pages: 1253 - 1268
Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine in Argentinean Adults
Lucila Rey-Ares
Ahuva Averin
Liping Huang
Original Research Open access 03 May 2024 Pages: 1235 - 1251
Nasal Staphylococcus aureus Carriage and Antimicrobial Resistance Profiles Among Community-Dwelling Adults in Jiangsu, China
Wenjing Hu
Yang Wang
Fengcai Zhu
Original Research Open access 03 May 2024 Pages: 1215 - 1233
Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan
Chun-Chi Yang
Chung-Feng Huang
Ming-Lung Yu
Original Research Open access 28 April 2024 Pages: 1199 - 1213
Correction to: Virologic Outcomes with Molnupiravir in Nonhospitalized Adult Patients with COVID-19 from the Randomized, Placebo-Controlled MOVe-OUT Trial
Julie M. Strizki
Jay A. Grobler
Carisa De Anda
Correction Open access 25 April 2024 Pages: 1159 - 1160
Modelling COVID-19 Vaccination in the UK: Impact of the Autumn 2022 and Spring 2023 Booster Campaigns
Diana Mendes
Sheeja Machira Krishnan
Jingyan Yang
Original Research Open access 25 April 2024 Pages: 1127 - 1146
Burden of Antimicrobial Resistance in Japan: A Systematic Literature Review and Meta-Analysis
Tetsuya Matsumoto
Akira Yuasa
Naohiro Yonemoto
Original Research Open access 25 April 2024 Pages: 1105 - 1125
Systematic Literature Review on the Incidence of Herpes Zoster in Populations at Increased Risk of Disease in the EU/EEA, Switzerland, and the UK
Alen Marijam
Nikki Vroom
Hilde Vroling
Original Research Open access 24 April 2024 Pages: 1083 - 1104
Prognostic Significance of NLR and PLR in COVID-19: A Multi-Cohort Validation Study
Marta Colaneri
Camilla Genovese
Andrea Gori
Brief Report Open access 21 April 2024 Pages: 1147 - 1157
Underlying Neural Mechanisms of Cognitive Improvement in Fronto-striatal Response Inhibition in People Living with HIV Switching Off Efavirenz: A Randomized Controlled BOLD fMRI Trial
Patrick G. A. Oomen
Charlotte S. Hakkers
Stefan du Plessis
Original Research Open access 20 April 2024 Pages: 1067 - 1082
Fungal Prosthetic Joint Infection: A Case Series and Review of the Literature
Victoria Starnes
Joan Duggan
Caitlyn Hollingshead
Original Research Open access 13 April 2024 Pages: 1051 - 1065
Effect of Regdanvimab on Mortality in Patients Infected with SARS-CoV-2 Delta Variants: A Propensity Score-Matched Cohort Study
Soyoon Hwang
Nan Young Lee
Ki Tae Kwon
Original Research Open access 12 April 2024 Pages: 1037 - 1050
Ritonavir: 25 Years’ Experience of Concomitant Medication Management. A Narrative Review
Romina Quercia
Giovanni Di Perri
Marta Boffito
Review Open access 12 April 2024 Pages: 1005 - 1017
Systematic Review of Heel Puncture-Related Osteomyelitis of the Calcaneus in Newborn Infants
Vidmi Taolam Martin
Ismail Ahmed Dhagey
Bin Yu
Review Open access 08 April 2024 Pages: 991 - 1004
Structured Literature Review to Identify Human Papillomavirus’s Natural History Parameters for Dynamic Population Models of Vaccine Impacts
Ibrahim Diakite
Bruno Martins
Elamin Elbasha
Review Open access 08 April 2024 Pages: 965 - 990
Seroprevalence and Shifting Endemicities of Hepatitis A Virus Infection in Two Different Geographical Areas in the Philippines
Josefina C. Carlos
Vinna Marie T. Quinones
Adriana Guzman-Holst
Original Research Open access 05 April 2024 Pages: 1019 - 1035
Modelling the Public Health Impact of MenACWY and MenC Adolescent Vaccination Strategies in Germany
Sebastian Gruhn
Manuel Batram
Oliver Damm
Original Research Open access 04 April 2024 Pages: 907 - 920
Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings: Results from the TANDEM Study
Stefan Schneider
Gary Blick
Alan Oglesby
Original Research Open access 03 April 2024 Pages: 891 - 906
Real-World Effectiveness of Dolutegravir/Lamivudine in People With HIV-1 in Test-and-Treat Settings or With High Baseline Viral Loads: TANDEM Study Subgroup Analyses
Paul Benson
Jennifer Kuretski
Alan Oglesby
Original Research Open access 03 April 2024 Pages: 875 - 889
Toxic-Induced Encephalopathy Following Chemsex in a Young HIV-Positive Male: A Complex Case of Acute Cognitive Impairment with Anterograde Amnesia and Behavioral Alterations
Alexy Inciarte
Lorena de la Mora
Josep Mallolas
Case Report Open access 03 April 2024 Pages: 647 - 658
Impact of Immunosuppressed Status on Prognosis of Carbapenem-Resistant Organisms Bloodstream Infections
Yuan-Yuan Li
Yan Chen
Bin Du
Original Research Open access 27 March 2024 Pages: 861 - 874
Estimated Incidence of Hospitalizations and Deaths Attributable to Respiratory Syncytial Virus Infections Among Adults in Germany Between 2015 and 2019
Aleksandra Polkowska-Kramek
Elizabeth Begier
Gernot Rohde
Original Research Open access 23 March 2024 Pages: 845 - 860
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States
Daniel Molnar
Elizabeth M. La
Desmond Curran
Original Research Open access 20 March 2024 Pages: 827 - 844
Estimation of Symptomatic Respiratory Syncytial Virus Infection Incidence in Adults in Multiple Countries: A Time-Series Model-Based Analysis Protocol
Robin Bruyndonckx
Aleksandra Polkowska-Kramek
Elizabeth Begier
Study Protocol Open access 18 March 2024 Pages: 953 - 963
Best Practices for Identifying Hospitalized Lower Respiratory Tract Infections Using Administrative Data: A Systematic Literature Review of Validation Studies
Germaine Hanquet
Christian Theilacker
Elizabeth Begier
Review Open access 18 March 2024 Pages: 921 - 940
Evaluating the Demand for Nucleic Acid Testing in Different Scenarios of COVID-19 Transmission: A Simulation Study
Yu-Yuan Wang
Wei-Wen Zhang
Ming-xia Jing
Original Research Open access 18 March 2024 Pages: 813 - 826
Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework
Sushma Kavikondala
Katrin Haeussler
Ekkehard Beck
Original Research Open access 18 March 2024 Pages: 779 - 811
Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia
Ru Han
Peter San Martin
Désirée A. M. van Oorschot
Original Research Open access 17 March 2024 Pages: 761 - 778
Part of 1 collection:

Digital Features - Infectious Diseases
Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine Among US Children with Underlying Medical Conditions
Mark H. Rozenbaum
Erica Chilson
Mark Atwood
Original Research Open access 16 March 2024 Pages: 745 - 760

1
2
…
20
Next page